Envestnet Asset Management
NVAX icon

Envestnet Asset Management’s Novavax NVAX Stock Holding History

Envestnet Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,332
Closed -$69.4K – 4786
2025
Q4 		$69.4K Sell
10,332
-12,569
-55% -$94.8K ﹤0.01% 4398
2025
Q3 		$199K Buy
+22,901
New +$178K ﹤0.01% 4324
2022
Q1 		– Sell
-2,037
Closed -$291K – 4018
2021
Q4 		$291K Buy
2,037
+5
+0.2% +$859 ﹤0.01% 3437
2021
Q3 		$421K Buy
2,032
+867
+74% +$191K ﹤0.01% 3081
2021
Q2 		$247K Sell
1,165
-1,120
-49% -$205K ﹤0.01% 3399
2021
Q1 		$414K Buy
+2,285
New +$455K ﹤0.01% 2951
2016
Q3 		– Sell
-186
Closed -$27K – 2998
2016
Q2 		$27K Sell
186
-40
-18% -$4.58K ﹤0.01% 2914
2016
Q1 		$23K Buy
226
+118
+109% +$12.7K ﹤0.01% 2943
2015
Q4 		$18K Buy
108
+43
+66% +$6.62K ﹤0.01% 2896
2015
Q3 		$9K Buy
+65
New +$14.6K ﹤0.01% 3005

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management's NVAX Position: Q1 2026 in Review

Envestnet Asset Management sold out of Novavax (NVAX) in Q1 2026, closing a stake of 10,332 shares — an estimated $69.4K sold.

Envestnet Asset Management first reported a position in NVAX in Q3 2015 and held it in 10 quarters. The position peaked at $421K in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Envestnet Asset Management reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 10,332 Novavax shares in Q1 2026, an estimated $69.4K.
  • Envestnet Asset Management first reported a position in Novavax in Q3 2015 and held it in 10 quarters.
  • Envestnet Asset Management's Novavax position peaked at $421K in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.